Business
Press Release May 11 2022
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 11-May-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Arformoterol Tartrate Inhalation Solution, 15 mcg (base)/2 mL Unit-dose Vial
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 11-May-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Arformoterol Tartrate Inhalation Solution, 15 mcg (base)/2 mL Unit-dose Vial View Attachment","length":434,"tagName":"div"}]